1. Home
  2. Labeler Index
  3. Ascend Laboratories, Llc
  4. 67877-426
  5. NDC Package Code: 67877-426-12 Mycophenolic Acid

NDC Package 67877-426-12 Mycophenolic Acid

Tablet, Delayed Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67877-426-12
Package Description:
120 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code:
67877-426
Proprietary Name:
Mycophenolic Acid
Non-Proprietary Name:
Mycophenolic Acid
Substance Name:
Mycophenolate Sodium
Usage Information:
Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted kidney. It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own.
11-Digit NDC Billing Format:
67877042612
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
120 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 485020 - mycophenolic acid 180 MG Delayed Release Oral Tablet
  • RxCUI: 485020 - mycophenolic acid (as mycophenolate sodium) 180 MG Delayed Release Oral Tablet
  • RxCUI: 485023 - mycophenolic acid 360 MG Delayed Release Oral Tablet
  • RxCUI: 485023 - mycophenolic acid (as mycophenolate sodium) 360 MG Delayed Release Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ascend Laboratories, Llc
    Dosage Form:
    Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • MYCOPHENOLATE SODIUM 180 mg/1
    • Pharmacologic Class(es):
  • Antimetabolite Immunosuppressant - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA208315
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-24-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 67877-426-12 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    67877042612J7518Mycophenolic acid180 MG1201120120

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    67877-426-05500 TABLET, DELAYED RELEASE in 1 BOTTLE
    67877-426-3810 BLISTER PACK in 1 CARTON / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (67877-426-33)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67877-426-12?

    The NDC Packaged Code 67877-426-12 is assigned to a package of 120 tablet, delayed release in 1 bottle of Mycophenolic Acid, a human prescription drug labeled by Ascend Laboratories, Llc. The product's dosage form is tablet, delayed release and is administered via oral form.

    Is NDC 67877-426 included in the NDC Directory?

    Yes, Mycophenolic Acid with product code 67877-426 is active and included in the NDC Directory. The product was first marketed by Ascend Laboratories, Llc on September 24, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 67877-426-12?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 120.

    What is the 11-digit format for NDC 67877-426-12?

    The 11-digit format is 67877042612. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-267877-426-125-4-267877-0426-12